Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Nov 21 2016

Full Issue

Anthem-Cigna Merger Goes To Trial In Final Chapter Of Obama's Antitrust Efforts

If completed, the merger between Anthem and Cigna and the deal between Aetna and Humana would leave the industry topped by three giant firms. While the decisions are expected before Donald Trump takes office, it's unclear where his administration will come down on mega-mergers like these.

The New York Times: The Future Of Health Care Mergers Under Trump

The proposed health insurance mega-merger between Anthem and Cigna heads to court on Monday, as the companies face off against a Justice Department seeking to block their $48 billion deal. It will be followed in just a few weeks by the trial for another proposed insurance mega-merger, between Aetna and Humana. (Abelson, 11/20)

The Wall Street Journal: Insurer Anthem To Defend Cigna Deal In Court

The trial starts Monday in the Justice Department’s challenge to health insurer Anthem Inc.’s $48 billion acquisition of reluctant partner Cigna Corp., a case that could produce unusual courtroom drama and be a last hurrah for President Barack Obama’s antitrust enforcers. The Justice Department has been aggressive in challenging mergers recently, but none of its efforts is bigger than its lawsuits challenging the Anthem-Cigna deal, the largest ever in the industry, and a $34 billion deal that would combine insurers Aetna Inc. and Humana Inc. A trial on the latter transaction begins Dec. 5. (Kendall and Wilde Mathews, 11/20)

St. Louis Post Dispatch: Consumers Should Pay Attention To Insurance Antitrust Case 

On Monday, the U.S. Department of Justice will begin arguing its case against what it says is the largest merger in the history of the health insurance industry. The Justice Department is challenging Anthem’s $54 billion acquisition of Cigna Corp., alleging that the deal will reduce competition among insurance carriers in dozens of markets, leading to increased market power for Anthem, which could lead to increased costs for consumers. Health care economists agree this is a case area consumers should care about. (Liss, 11/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF